D. E. Shaw & Co., Inc. - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 106 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,064,000
-76.1%
261,488
-73.5%
0.00%
-75.0%
Q1 2021$4,444,000
+1.1%
985,316
+10.3%
0.00%0.0%
Q4 2020$4,396,000
-11.4%
893,598
+6.9%
0.00%
-20.0%
Q3 2020$4,959,000
+272.0%
836,297
+66.9%
0.01%
+150.0%
Q2 2020$1,333,000
+41.8%
501,180
+4.0%
0.00%
+100.0%
Q1 2020$940,000482,0170.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders